Biodelivery Sciences International Overview
Biodelivery Sciences International (BDSI) has a P/E ratio of 6.82, below the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow6.82
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Biodelivery Sciences International (BDSI) currently reports a P/E ratio of 6.82. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore Biodelivery Sciences International's P/E ratio history and peer comparisons.
Biodelivery Sciences International's P/E ratio of 6.82 is lower than the Healthcare sector average of 25.9. That is roughly 73.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Biodelivery Sciences International's market price to a fundamental measure such as earnings, sales, or book value. At 6.82, BDSI can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 6.82, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Biodelivery Sciences International, and consider following BDSI for alerts when major investors trade the stock.
Biodelivery Sciences International is classified in the Healthcare sector. On P/E ratio, it currently shows 6.82 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDSI with unrelated industries.
